1. World Health Organization. Depression. Genebra: WHO; 2008.
2. Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. 2017;208:56-61.
3. World Health Organization. Depression: fact. Geneva: WHO; 2017.[http://www.who.int/mediacentre/factsheets/fs369/en/]. Accessed 22 Jun 2018.
4. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;351:365-72.
5. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence?. Nutr Rev. 2009;67:481–492.
6. Cass WA, Smith MP, Peters LE: Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci. 2006;1074:261–71.
7. Schneider [7]
8. Kjærgaard M, Joakimsen R, Jorde R. Lowserum 25-hydroxyvitamin D levels are associated with depression in an adult Norwegian population. Psychiatry Res. 2011;190:221-5.
9. Stokes CS, Grünhage F, Baus C, Volmer DA, Wagenpfeil S, Riemenschneider M, et al. Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease. Clin Nutr. 2016;35:950-7.
10. Bahrami A, Mazloum SR, Maghsoudi S, Soleimani D, Khayyatzadeh SS, Arekhi S, et al. High dose vitamin D supplementation is associated with a reduction in depression score among adolescent girls: a nine-week follow-up study. J Diet Suppl. 2018;15:173-82.
11. Jhee JH, Kim H, Park S, Yun H-R, Jung S-Y, Kee YK, et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. Plos One. 2017;12:e0171009.
12. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008;65:508-12.
13. Sepehrmanesh Z, Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi Z, et al. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J Nutr. 2016;146:243-8.
14. Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6:1501-18.
15. Shaffer JA, Edmondson D, Wasson LT, Falzon L, Homma K, Ezeokoli N, et al. Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosom Med. 2014;76:190-6.
16. Montgomery SA, Asberg M. Anew depression scale designed to be sensitive to change.Br J Psychiatr. 1979;134:382-9.
17. Organização Mundial da Saúde. CID-10: Classificação Estatística Internacional de Doenças com disquete Vol. 1. Edusp, 1994.
18. C. Dumont, S. Gillette-Guyonnet, S. Andrieu, C. Cantet, P.J. Ousset and B. Vellas, Baisse rapide du Mini Mental State Examination: étude REAL.FR, La Revue de Médecine Interne, 24, (345s), (2003).
19. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266-77.
20. Bandeira F, Griz L, Freese E, Lima DC, Thé AC, Diniz ET, et al . Vitamin D deficiency and its relationship with bone mineral density among postmenopausal women living in the tropics. Arq Bras Endocrinol Metab.2010;54: 227-232.
21. Pathak S, Nisar MA, Rosenthal DS.Vitamin D deficiency (VDD) and major depressive disorder (MDD): a causal or casual association? J. Endrocine Society. 2012. [http://press.endocrine.org/doi/abs/10.1210/endo-meetings.2012.BCH.3.SAT-377]. Acessed 18 oct 2016.
22. Sepehrmanesh Z,Kolahdooz F, Abedi F, Mazroii N, Assarian A, Asemi A, Esmailzadeh A. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized, controlled clinical trial. J. Nutr.,Rockville. 2016;146:243-48.
23. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-10.
24. Overall[r1], supplementation with 50 kIU vitamin D/wk for 8 wk in patients with MDD had beneficial effects on markers of glucose metabolism and oxidative stress, but it did not affect FPG, QUICKI, lipid profiles, or serum hs-CRP concentrations
25. Brazilian Association of Companies in Research.Criterion of economic classification in Brazil. São Paulo: 2015.
26. Whelton PK, Carey RM, Aronow WS, Casey Jr DE, Collins KJ, Dennison Himmelfarb C.Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017.
27. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109(2Supl.1):1-76.
28. Cesar LA, Ferreira JF, Armaganijan D, Gowdak LH, Mansur AP, Bodanese LC, et al. Diretriz de Doença Coronária Estável. Arq Bras Cardiol. 2014;103(2Supl.2): 1-59.
29. Presti C, Miranda Jr F, Casella IB, De Luccia N, Covre MR. Projeto diretrizes SBACV: Doença arterial periferia obstrutiva de membros inferiores: diagnóstico e tratamento. Recife: Sociedade Brasileira de Angiologia e Cirurgia Vascular. 2015.
30. American Heart Association. Ejection Fraction heart failure measurement [https://www.heart.org/en/health-topics/heart-failure/diagnosing-heart-failure/ejection-fraction-heart-failure-measurement]. Acessed 25 May 2019.
31. William T, Cefalu MD. Standards of medical care in diabetes-2017: American Diabetes Association (ADA). Diabetes Care. 2017;40 (Supp 1):S1-S134.
32. Milech A, Perez angelucci A, Golbert A, Matheus A, Carrilho Faria AJ, Ramalho AC, et al. Diretrizes da Sociedade Brasileira de Diabetes (2015-2016). São Paulo: A.C. Farmacêutica; 2016.
33. Maia AL, Scheffel RS, Meyer EL, Mazeto GM, Carvalho GA, Graf H, et al. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol. 2013;57:205-24.
34. Brenta G, Vaisman M, Sgarbi JA, Bergoglio LM, Andrada NC, Bravo PP, et al. Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metab. 2013;57:265-91.
35. KDIGO.clinical practice guideline for the evaluation and management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1-150.
36. Bandeira F, Griz L, Chaves N, Carvalho NC, Borges LM, Lazaretti-Castro M, et al. Diagnosis and management of primary hyperparathyroidism: a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endocrinol Metab. 2013;57:406-24.
37. Malachias Bolívar MV, Souza Weimar KSB, Plavnik FL, Rodrigues CIS, Brandão AA, Neves MFT. 7a Diretriz Brasileira de Hipertensão Arterial. Brazilian Journal of Hipertension.2017;24:2-91
38. Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol 2017; 109(2Supl.1):1-76
39. Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, & Ng CH. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Am J Psychiatry. 2016;173:575–587.